|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Sleep Disorders Center, Department of Neurology, and Statistic Unit, IRCCS H San Raffaele, Milan, Italy.
Correspondence to: Marco Zucconi, MD, Sleep Disorders Center, Department of Neurology, San Raffaele Scientific Institute and Hospital, Via Stamira dAncona 20, 20129 Milan, Italy; e-mail: zucconi.marco{at}hsr.it
| Abstract |
|---|
|
|
|---|
Design: Clinical setting.
Patients: Twelve children (age range, 3 to 6 years) with highly suspected uncomplicated OSA who underwent PSG and P-M on 2 consecutive laboratory nights in a balanced manner.
Measurements: Respiratory indexes were compared for P-M (automated analysis), hand-scored revised P-M (P-Mrev), and PSG. Analysis of contingency for cutoff levels of respiratory disturbance index (RDI) of 5 and 10 and level of agreement between P-M, P-Mrev, and PSG by the concordance method were evaluated.
Results: Nine of twelve children (75%) had a PSG RDI > 5, while 41.7% had an RDI > 10, indicating moderate-to-severe OSA. P-M sensitivity (78%) increased with the increase of the RDI cutoff, and P-Mrev sensitivity reached 100% at the cutoff of 10. The specificity was low for RDI > 5 and increased only modestly at RDI > 10 (P-Mrev, 57%). Seven of 12 children (increasing to 9 children with P-Mrev) and 9 of 12 children (increasing to 11 children with P-Mrev) were correctly classified by the P-M unit when cutoffs of 5 and 10 were considered, respectively. As far as the agreement level is concerned, P-M underestimated the incidence of obstructive hypopnea and overestimated the number of central apnea cases. P-Mrev improved the latter measure.
Conclusion: Based on these data, the P-M device cannot be advocated for common use in a clinical setting, but it may have a role in urgent screening for highly suspected moderate-to-severe OSA.
Key Words: childhood obstructive sleep apnea nocturnal polysomnography respiratory monitoring unattended device validation study
| Introduction |
|---|
|
|
|---|
The aim of this study was twofold: to test, in a laboratory setting, the P-M device in comparison to an attended classic nocturnal PSG in children with suspected OSA; and to verify the accuracy of the automatic scoring of the device with or without a revised analysis by visual editing of the raw data. The verification was relative to PSG results.
| Materials and Methods |
|---|
|
|
|---|
From a clinical history, the following features were found (mean ± SD): age, 4.0 ± 0.8 years; body mass index, 16.6 ± 3.5; snoring onset, 18.7 ± 11.3 months; familiarity for habitual snoring in 10 of 12 cases (80%); excessive daytime sleepiness in 6 of 12 patients (50%); and failure to thrive in 3 of 12 patients (25%). Reported apneas, daytime irritability, forced daytime oral respiration, and recurrent upper airway infections were present in all the children. In all the children except one, who previously had an adenoidectomy, there was a moderate-to-severe adenotonsillar hypertrophy.
The whole group underwent full-night PSG (Grass, Digital System Heritage; Astro-Med; West Warwick, RI) and a seven-channel unattended recording with P-M for 2 consecutive nights in the sleep laboratory in a balanced manner: six children underwent P-M the first night and PSG the second night, and the other six children were recorded in the opposite order. The accompanying parent was allowed to stay in the recording room and instructed how not to interfere. The time schedule (9 PM admittance, 10:30 PM lights out, 7 AM lights on) was the same for both days.
The P-M unit is a small device that can be attached to the patient and, in the standard setting, has seven channels of recording: (1) flow sensors for oronasal breath flow (thermistors); (2) a laryngeal microphone for detection of snoring sound; (3) an ECG lead; (4) a stress-sensitive belt for thoracic effort, and two other belts for abdominal effort (5) and body position (6); and (7) a pulse oximeter with a finger probe for detection of percentage of arterial oxygen saturation (SaO2). A computer-based analysis automatically calculates apnea, hypopnea, and desaturation events, and the index of each variable per hour of recording time, based on the setup of each variable. PSG included two EEG channels (C3-A2 or C4-A1 and O1-A2 or O2-A1), two electrooculographic channels (right outer canthus and left outer canthus), submental electromyogram (genioglossus muscle), ECG (one lead), laryngeal microphone, oronasal (thermistor) flow, thoracic and abdominal effort (belt), body position, and finger probe oximetry.
The evaluation of both PSG and P-M recordings was done by the same examiner in different times, in different orders and in blinded fashion, for each child examined. For both PSG and P-M events, the following were evaluated: obstructive and mixed apnea (OA), central apnea (CA), not related to previous body movements and with oxygen desaturation of > 4%; obstructive hypopnea (OH), considered as a reduction of > 50% in the thermistor signal associated with oxygen desaturation of > 4%; and desaturation events (DEs) > 4%. The total number of apnea and hypopnea events (AHT), respiratory disturbance index (RDI) per hour, and oxygen desaturation index (ODI) per hour were calculated according to the total time in bed for both types of recording. The lowest percentage of SaO2 (SaO2%) was calculated as the minimum SaO2 level associated with events, and the mean low SaO2% was measured as the mean of the peak SaO2% level associated with each single event. In order to discern motion artifacts, trend and event graphs of oximetry were printed and the oximeter pulse waveform was recorded.
For the P-M unit, both automated and hand-scored revised data analyses (revised POLY-MESAM [P-Mrev]) were provided and assessed. For P-Mrev, the automatic analysis served as a base for scored apnea and hypopnea events. The reviewer, having an overview of all channels, recorded snoring louder at the end of events, pulse rate, and SaO2% synchronous variations with respiratory events. He evaluated and corrected the automatic analysis, taking into account possible artifacts and errors.
The analysis of sleep for PSG recording was performed according to Rechtschaffen and Kales.12 The minimum duration of apnea-hypopnea events was set at 8 s for each scoring. There is little consensus on the level of RDI or ODI that defines a child as "affected" or "nonaffected" with OSA; different levels of 1, 5, 10, or 15 are used in different studies.1 13 14 We chose different thresholds for RDI and ODI (5 and 10) to measure sensitivity, specificity, positive predictive values (PPVs), and negative predictive values (NPVs). These threshold levels are higher than what is generally considered abnormal,15 but better serve to identify children with a clinically significant level of respiratory events who exhibit at least a moderate degree of OSA.13 Affected or nonaffected subjects as defined by different PSG cutoff levels were compared by means of contingency tables. Ninety-five percent confidence intervals (CIs) were calculated according to the efficient-score method, after correction for the continuity, as the Gaussian approximation is not well suited for small proportions.16 Pearson correlation coefficients were also calculated. Agreement between P-M, P-Mrev, and PSG indexes was analyzed according to the Bland and Altman method of concordance.17 Since a relationship between the difference scores and the size of the measurements emerged, a logarithmic transformation of the raw data were employed. The hypothesis that the mean difference was equal to zero was examined by a paired t test. The mean and 95% limits of the CI of the difference between the two methods, after anti-log transformation, for each analyzed parameter are presented. The anti-log difference between two values on a log scale is a dimensionless ratio; therefore, the statistical significance was obtained when 95% CI of the difference was entirely above or below 1.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The study shows relevant correlation between data collected by the two systems only when we used the revised data for RDI, AHT, and OA, but not for OH and CA. The sensitivity of the device made it possible to detect suspected OSA especially when revised data and higher thresholds were used. The device was less specific, regardless of the RDI cutoff or the revision of the data; however, despite difficulties with the probes and artifacts on the signals, 11 of the 12 children were correctly classified by the P-Mrev for discrimination of an overt OSA (RDI > 10). The agreement test showed that the P-M device underestimates respiratory events, regardless of the visual reanalysis of the raw data, but the means, using the Bland and Altman method, differed only a few units for each parameter considered. The greatest difference involved CA scoring, which improved using the revised analysis. The point of CA analysis was to underscore that central events were marked, even if no displacement was noted on both thoracic and abdominal sensors. Without EEG, electrooculography, esophageal pressure measures, or inductance plethysmography, the reliability of this measurement is low for signal scoring. During PSG, one can intervene to correct signals, unlike the case of an unattended device. For the hypopneas, the explanation for underscoring events may lie in the definition of hypopnea. Some events were unrecognized by the automatic analysis but were added with the revision of the data, which also considered borderline events (ie, a 40% decrease in oronasal flow but with desaturation) as well as for the PSG. Other factors may have influenced the difference in agreement between P-M and PSG. The quality of the signal from the thermistor, in children, is very sensitive to body position or movements during the night and the night-to-night variability of RDI.18 However, a recent study19 has verified the variability of respiratory measures in children with suspected OSA and found little clinically significant night-to-night variability and no first-night effect. No study addressed night-to-night variability in respiratory parameters measured by unattended devices in children. Of course, our protocol included 2 consecutive nights of recording, with very low potential night-to-night variability.
We are concerned with the major limitations of study, due to the low number of children studied and the very high OSA probability in our sample, confining the results to a group of highly clinically selected OSA candidates. Indeed, it is very difficult for very young children (and parents) to accept two consecutive in-laboratory PSGs or portable monitoring sessions. Thus, an attempt to increase the number of subjects was unproductive. However, the sample is representative of uncomplicated childhood OSA (associated with adenotonsillar hypertrophy and/or obesity).1 Another limitation for the application and generalization of our results was the laboratory setting of the study. Perhaps the sensitivity and specificity may differ in a home setting as opposed to a sleep laboratory; however, we attempted to simulate a normal and constant environment for the children by obtaining the presence of both parents in the laboratory, television or videorecording viewing before retiring to the sleep room, etc., and there was no problem noted in adapting to the laboratory.
Different portable recordings have been utilized for detecting OSA in children8 but only a few have been validated. Pulse oximetry has been studied in some samples, obtaining results not sufficient to exclude OSA when the results are negative, since obstructive events in some patients may lead to arousal and consequent sleep disturbances but without significant desaturations.20 21 However, a large-scale study22 in OSA candidates for adenotonsillectomy found a 97% PPV but an NPV of 47%, indicating that oximetry was useful only when results are positive. Only ambulatory PSG (as the Compumedics PS2 system [Compumedics; Abbotsford, Victoria, Australia] or the Edentrace I and II [Edentec; Eden Prairie, MN]) showed unequivocal reliability in adults,19 but they have been tested in a very low number of young children; these devices, however provided satisfactory correlation results.23 24
Our results with the P-M device, although not wholly satisfactory, indicate that further validation studies must be conducted before recommending the wide use of this unattended device for OSA diagnosis in children. Larger samples should be evaluated, since the majority of studies in children have involved only a small number of patients. In conclusion, to date, the P-M cannot be advocated for common use in a clinical setting. However, it may have a role in reducing the waiting list for PSG in highly suspected moderate-to-severe OSA in children when treatment is urgently needed.
| Acknowledgements |
|---|
| Footnotes |
|---|
Received for publication July 23, 2002. Accepted for publication February 13, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. E. Montgomery-Downs, L. M. O'Brien, T. E. Gulliver, and D. Gozal Polysomnographic Characteristics in Normal Preschool and Early School-Aged Children Pediatrics, March 1, 2006; 117(3): 741 - 753. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |